🔗 Share this article

A shadow market for unapproved slimming drugs is propelled by social media fitness personalities and vendors on communication apps, based on new investigations.

Experimental Drug Acquiring Popularity Online

Retatrutide, which remains in clinical trials, is being advertised by social media influencers for its alleged weight-reducing effects. Followers are urged to contact these profiles privately for supplier links, while also receiving promotional offers.

Active Commerce on Messaging Platforms

Separately, a flourishing trade exists on messaging services, where communities with thousands of members share “before and after” images, injection guides and claims of next-day British shipping. Vendors promote the drug there before directing buyers to other platforms for purchases.

Understanding The Experimental Drug

Retatrutide is an investigational injectable created by US drugmaker Eli Lilly. The drug affects three gut hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Early trials indicate it could assist individuals lose up to a quarter of their total weight. Nicknamed the “triple G”, the substance is being promoted digitally as the next Ozempic.

Medical Professionals Voice Worries

Nevertheless, physicians and pharmacists have warned that the distribution of what remains an unlicensed drug in the UK is a cause for concern and could lead to individuals administering substances of uncertain source.

Several professionals stated the demand for the experimental drug could be linked to the increasing price of licensed weight loss treatments such as Mounjaro.

Legal Position and Enforcement

Marketing retatrutide on TikTok or messaging apps is illegal in the UK, as it is an unlicensed medication that must not be marketed or distributed for personal consumption under the Human Medicines Regulations 2012.

Some influencers try to circumvent the regulations by referring to the drug as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a controlled substance, but advertising and supply can still violate medicines, marketing, and consumer laws, potentially leading to fines, prosecution or imprisonment.

Service Response and Content Removal

Based on TikTok, the service has taken down violative content and banned related hashtags and query recommendations. The company stated it was committed to keeping the platform secure and allocating resources in enhancing enforcement strategies.

Online Trading Activities

Research also discovered communities with up to 9,000 participants selling retatrutide using Telegram's integrated search feature, which operates like a public directory. Typing “retatrutide” immediately brings up channels with thousands of users, filled with images of slimming results, glowing testimonials and detailed instructions for mixing or administering at home.

After minutes of joining one group, a seller posted WhatsApp details, where most purchases take place. The vendor provided an instruction manual and guaranteed delivery within two days. When asked whether the product was authentic, one vendor responded: “You can’t be sure.” Another shared a photo of a supposed laboratory certificate. Not one asked about body mass, medical conditions or past usage.

Item Information and Pricing

Inside these groups, posts display dark colored parcels with Royal Mail stickers, stating to include new batches. One communication stated: “It took eight of us to load them this morning.”

Customers can select between dry substance containers, prepared at residence with sterile water, or pre-filled injectors typically sold at 160 pounds for 20 milligrams. When questioned how much time a injector should last, sellers give conflicting answers ranging from a several days to “depends on your body”.

Service Moderation and Security Measures

A spokesperson for Telegram said it actively moderated harmful content on its platform including content that encouraged the “misuse of controlled medications”. The company noted that it removed “millions of pieces of harmful content each day”.

Medical Professional Cautions

“Individuals are injecting substances they cannot confirm. Although the science behind this drug is valid, these online versions may not include what they advertise,” stated Jason Murphy, the head of pharmacy at Chemist4U.

Dr Crystal Wyllie of Asda Online Doctor connected the surge in interest to current price rises for approved weight-loss medications such as Mounjaro. “With prices increasing, individuals are turning to social media. But fake treatments are highly dangerous. You can’t be certain what’s inside or whether the environment they were produced in was clean,” she said.

Her team has already encountered individuals injured by self-injection from unconfirmed sources. “We recognize the disappointment, but buying from messaging apps or WhatsApp is taking chances with your health,” said Wyllie. “These substances could be impure or improperly measured.”

Manufacturer Statement

A representative from the pharmaceutical company stated the substance was in phase 3 clinical trials and had not been reviewed or approved by any regulatory agency globally. “Consequently at this point no one can sell [it] for human use,” they explained, noting that any item “falsely representing itself as a Lilly investigational product not yet approved … may subject users to possibly significant medical dangers”.